BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18711189)

  • 1. Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.
    Brown AP; Wendler DS; Camphausen KA; Miller FG; Citrin D
    J Clin Oncol; 2008 Aug; 26(24):3987-94. PubMed ID: 18711189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research Statement.
    Levit LA; Peppercorn JM; Tam AL; Marron JM; Mathews DJH; Levit K; Roach N; Ratain MJ
    J Clin Oncol; 2019 Sep; 37(26):2368-2377. PubMed ID: 31343905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in Oncology.
    Parseghian CM; Tam AL; Yao J; Ensor J; Ellis LM; Raghav K; Overman MJ
    JAMA Oncol; 2019 Mar; 5(3):402-405. PubMed ID: 30383128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underreporting of Research Biopsies from Clinical Trials in Oncology.
    Parseghian CM; Raghav K; Wolff RA; Ensor J; Yao J; Ellis LM; Tam AL; Overman MJ
    Clin Cancer Res; 2017 Nov; 23(21):6450-6457. PubMed ID: 28754815
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of research biopsies in clinical trials: are risks and benefits adequately discussed?
    Overman MJ; Modak J; Kopetz S; Murthy R; Yao JC; Hicks ME; Abbruzzese JL; Tam AL
    J Clin Oncol; 2013 Jan; 31(1):17-22. PubMed ID: 23129736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.
    Peppercorn J; Shapira I; Collyar D; Deshields T; Lin N; Krop I; Grunwald H; Friedman P; Partridge AH; Schilsky RL; Bertagnolli MM
    J Clin Oncol; 2010 May; 28(15):2635-40. PubMed ID: 20406927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ethical use of mandatory research biopsies.
    Olson EM; Lin NU; Krop IE; Winer EP
    Nat Rev Clin Oncol; 2011 Aug; 8(10):620-5. PubMed ID: 21808265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misunderstandings, mandatory biopsies, and conflicts of interests in clinical trials: a coercive cocktail?
    McNeil CM; Tattersall MHN
    Lancet Oncol; 2017 Jul; 18(7):851-852. PubMed ID: 28677563
    [No Abstract]   [Full Text] [Related]  

  • 10. Publication and reporting conduct for pharmacodynamic analyses of tumor tissue in early-phase oncology trials.
    Freeman GA; Kimmelman J
    Clin Cancer Res; 2012 Dec; 18(23):6478-84. PubMed ID: 22912391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.
    Agulnik M; Oza AM; Pond GR; Siu LL
    J Clin Oncol; 2006 Oct; 24(30):4801-7. PubMed ID: 17050865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward improved understanding of the ethical and clinical issues surrounding mandatory research biopsies.
    Peppercorn J
    J Clin Oncol; 2013 Jan; 31(1):1-2. PubMed ID: 23129739
    [No Abstract]   [Full Text] [Related]  

  • 14. Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation.
    Helft PR; Daugherty CK
    J Clin Oncol; 2006 Oct; 24(30):4793-5. PubMed ID: 17050863
    [No Abstract]   [Full Text] [Related]  

  • 15. Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer Center.
    Olympios N; Collet L; Paesmans M; Jungels C; Kotecki N; Awada A; Aftimos P
    Oncologist; 2021 Dec; 26(12):1062-1070. PubMed ID: 34286890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.
    El-Osta H; Hong D; Wheler J; Fu S; Naing A; Falchook G; Hicks M; Wen S; Tsimberidou AM; Kurzrock R
    Oncologist; 2011; 16(9):1292-8. PubMed ID: 21859821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nondiagnostic conjunctival map biopsies for sebaceous carcinoma.
    Koreen IV; Flint A; Nelson CC; Frueh BR; Elner VM
    Arch Ophthalmol; 2009 Aug; 127(8):961-3. PubMed ID: 19667331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from clinical trial queries on small biopsy collections: importance of rapid on-site evaluation.
    Voyten J; Holtzman MP; Pantanowitz L; Dhir R; Beasley HS; Cuda J; Monaco SE
    J Am Soc Cytopathol; 2020; 9(5):461-468. PubMed ID: 32499137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliciting adverse effects data from participants in clinical trials.
    Allen EN; Chandler CI; Mandimika N; Leisegang C; Barnes K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):MR000039. PubMed ID: 29372930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of biopsies in clinical research.
    Cannistra SA
    J Clin Oncol; 2007 Apr; 25(11):1454-5. PubMed ID: 17416872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.